Commonwealth Equity Services’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$57.7K Sell
21,050
-1,959
-9% -$6.2K ﹤0.01% 4185
2025
Q4
$85.1K Buy
23,009
+5,500
+31% +$17.8K ﹤0.01% 4130
2025
Q3
$46K Sell
17,509
-5,000
-22% -$9.67K ﹤0.01% 4169
2025
Q2
$22K Buy
22,509
+9,772
+77% +$9.79K ﹤0.01% 4207
2025
Q1
$18K Sell
12,737
-2,000
-14% -$3.69K ﹤0.01% 4130
2024
Q4
$32K Sell
14,737
-4,500
-23% -$10.5K ﹤0.01% 4015
2024
Q3
$32K Hold
19,237
﹤0.01% 3970
2024
Q2
$43K Buy
19,237
+5,000
+35% +$11.8K ﹤0.01% 3907
2024
Q1
$38K Buy
+14,237
New +$34.6K ﹤0.01% 3920
2015
Q3
Sell
-3,575
Closed -$292K 2170
2015
Q2
$292K Sell
3,575
-40
-1% -$3.92K ﹤0.01% 1662
2015
Q1
$335K Buy
+3,615
New +$233K ﹤0.01% 1566

Other funds holding ESPR